Stock screener

PCVX

Conviction 86HealthcareScan · Tue, Sep 8, 2026
PCVX$60.36-1.31%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
4
2
6
4
Vol MA14 1.05M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Vaxcyte, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vaxcyte.com
Price60.36
Change-1.31%
Gap-2.84%
Rel volume1.32×
Avg volume979.52K
Avg $ vol59.58M
SMA 2060.70
SMA 5058.26
SMA 20054.12
Price vs 50+3.60%
Price vs 200+11.54%
MA stackbullish
50/200 cross
Supertrendup · 55.51
RSI (14)53
MACD hist-0.22
MACD crossbear · 6d
Stoch %K / %D34 / 47
ADX (14)35
+DI / −DI20 / 13
RSI divergence
MACD divergence
ATR %+3.81%
ADR %3.49%
52w high63.30
52w low30.89
From 52w high-4.64%
Above 52w low+95.43%
New 52w highNo
SqueezeOn · 4d
Bollinger width8.00%
%B0.43
Donchian pos45.81%
Donchian high63.98
Donchian low57.30
AVWAP (52w high)55.73
vs AVWAP high+8.30%
AVWAP (52w low)50.62
vs AVWAP low+19.24%
OBV trendFlat
Chaikin MF (20)0.01
Today vs 20d1.32×
Avg vol (14d)1.05M
Avg vol (20d)979.52K
Avg $ vol (20d)59.58M
Market cap8.98B
RS 3m (vs SPY)+24.71%
RS 6m (vs SPY)-11.39%
RS line new highNo
Trend template8/8
Technical rank65.1
1 week-0.63%
1 month+3.94%
3 months+30.28%
6 months+1.75%
1 year+82.80%
YTD+29.92%
P/E-11.72
P/B3.26
P/S
P/FCF-13.42
EPS-5.63
Div yield
ROE-27.80%
ROA-24.43%
Debt/Eq
Current5.72
EV/EBITDA-9.70
Gross margin
Net margin
Rev growth
EPS growth-65.25%
Price target114.33
Target upside89.41%
Analyst ratingBuy
Institutional131.65%
Ent. value8.8B
Revenue
Net income-284.3M
Gross profit
Free cash flow-669.29M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out144.4M
Employees507
ListedFri, Jun 12, 2020
Free float126.82M
Float %87.8%
Short interest14.8M
Days to cover15.8d
Short volume62.2%
Squeeze score68 / 100
Next earnings
EPS forecast
Last EPS vs est−$1.97 vs −$1.47
Last surprise-34.0% miss
Setup gradeA
Conviction86 / 100
Pattern quality
Tech rank65.1 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance63.44
Support53.53
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PCVX · 7 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-07-16
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-13
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-12
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-14
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-15
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-28
Buy$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-03-05
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in PCVX · 1 buy · 9 sells

InsiderSideShares
Wassil Jim
CHIEF OPERATING OFFICER · Common Stock · 2026-09-02
Tax1.43K
Cowan Elvia
SVP, Finance & CAO · Common Stock · 2026-09-02
Tax326
Dhaliwal Harpreet S.
Chief Technical Ops Officer · Common Stock · 2026-09-02
Tax659
GUGGENHIME ANDREW
PRESIDENT AND CFO · Common Stock · 2026-09-02
Tax1.43K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Common Stock · 2026-09-02
Tax3.43K
Wassil Jim
CHIEF OPERATING OFFICER · Common Stock · 2026-09-01
Sell924
Wassil Jim
CHIEF OPERATING OFFICER · Common Stock · 2026-09-01
Sell303
Wassil Jim
CHIEF OPERATING OFFICER · Stock Option (right to buy) · 2026-09-01
Exercise2.25K
Wassil Jim
CHIEF OPERATING OFFICER · Common Stock · 2026-09-01
Exercise2.25K
Wassil Jim
CHIEF OPERATING OFFICER · Common Stock · 2026-09-01
Sell1.54K

SEC filings

EDGAR filings in PCVX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.